IMARC Group’s report titled “Formulation Development Outsourcing Market Report by Service (Pre-formulation Services, Formulation Optimization), Dosage Form (Injectable, Oral, Topical, and Others), Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Government and Academic Institutes), and Region 2024-2032“. The global formulation development outsourcing market size reached US$ 24.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/formulation-development-outsourcing-market/requestsample
Factors Affecting the Growth of the Formulation Development Outsourcing Industry:
- Rising Focus on Cost Efficiency:
Outsourcing formulation development save costs for pharmaceutical companies. By partnering with specialized contract development and manufacturing organizations (CDMOs), companies can avoid the investment required to establish and maintain in-house formulation development capabilities. This includes savings on equipment, facilities, and the hiring and training of specialized personnel. CDMOs often operate on economies of scale, providing services at a lower cost due to their larger operations and expertise. Additionally, outsourcing allows companies to convert fixed costs into variable costs, paying only for the services they need. This flexibility is particularly beneficial for small and medium-sized enterprises that may not have the resources to invest heavily in in-house development.
- Increasing Drug Development Complexity:
The rising focus on complex formulations, including biologics, biosimilars, and specialty drugs, is bolstering the market growth. These complex formulations present unique challenges that require specialized expertise and infrastructure, which many pharmaceutical companies may lack in-house. CDMOs are equipped with the necessary capabilities to handle these complexities, offering services, such as advanced analytical testing, stability studies, and scalable manufacturing processes. The development of novel drug delivery systems like nanotechnology-based formulations and targeted delivery mechanisms, further adds to the complexity. Outsourcing to CDMOs allows pharmaceutical companies to tap into this specialized knowledge and infrastructure, ensuring that their complex drug candidates are developed efficiently and to high-quality standards.
- Access to Expertise and Advanced Technologies:
Partnering with CDMOs provides pharmaceutical companies access to a wealth of expertise and advanced technologies that may not be available internally. CDMOs employ highly skilled scientists and researchers with specialized knowledge in various aspects of formulation development, including complex drug formulations, novel drug delivery systems, and regulatory requirements. These organizations also invest in state-of-the-art equipment and cutting-edge technologies, which can enhance the quality and efficiency of formulation development processes. Pharmaceutical companies can improve the chances of success for their drug candidates by leveraging the expertise and technological capabilities of CDMOs.
Leading Companies Operating in the Global Formulation Development Outsourcing Industry:
- Aizant Drug Research Solutions Private Limited
- Catalent Inc.
- Charles River Laboratories
- Reddy’s Laboratories Ltd.
- Emergent BioSolutions Inc.
- Intertek Group plc
- Irisys LLC (Recro Pharma)
- Laboratory Corporation of America Holdings
- Lonza Group AG
- Piramal Pharma Solutions
- Quotient Sciences
- Syngene International Limited (Biocon Limited)
- Thermo Fisher Scientific Inc.
Formulation Development Outsourcing Market Report Segmentation:
By Service:
- Pre-formulation Services
- Discovery and Preclinical Services
- Analytical Services
- Formulation Optimization
- Phase I
- Phase II
- Phase III
- Phase IV
Formulation optimization represents the largest segment as it assists in enhancing drug performance.
By Dosage Form:
- Injectable
- Oral
- Topical
- Others
Injectable holds the biggest market share on account of the rising prevalence of biologics and biosimilars.
By Application:
- Oncology
- Genetic Disorders
- Neurology
- Infectious Diseases
- Respiratory
- Cardiovascular
- Others
Oncology accounts for the largest market share due to the increasing demand for targeted therapies.
By End User:
- Pharmaceutical and Biopharmaceutical Companies
- Government and Academic Institutes
Pharmaceutical and biopharmaceutical companies exhibit a clear dominance in the market, driven by the rising focus on core competencies.
Regional Insights:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the formulation development outsourcing market, which can be attributed to favorable government initiatives.
Global Formulation Development Outsourcing Market Trends:
Stringent regulatory requirements aimed at ensuring the safety, efficacy, and quality of drugs are impelling the market growth. CDMOs have established quality systems and regulatory expertise, helping clients comply with various guidelines and standards set by regulatory authorities. By outsourcing formulation development to CDMOs, companies can benefit from their experience in preparing regulatory submissions, conducting necessary tests and validations, and maintaining compliance throughout the development process. This reduces the risk of regulatory delays or rejections, which can be costly and time-consuming.
Pharmaceutical companies are increasingly focusing on their core competencies, such as drug discovery and marketing, and outsourcing non-core activities like formulation development, to optimize the overall business performance.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
